Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ProSomnus, Inc. - Common Stock
(NQ:
OSA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ProSomnus, Inc. - Common Stock
< Previous
1
2
3
Next >
OSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023
March 27, 2024
OSA stock results show that ProSomnus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 26, 2024
Via
Benzinga
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
March 26, 2024
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
March 15, 2024
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
Roth MKM Maintains Buy Rating for ProSomnus: Here's What You Need To Know
September 26, 2023
Via
Benzinga
Earnings Scheduled For March 26, 2024
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Month
February 23, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
February 22, 2024
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
February 20, 2024
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
January 30, 2024
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
January 29, 2024
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
January 08, 2024
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 19, 2023
Via
Benzinga
Why Is Sleep Devices Focused ProSomnus Stock Soaring Today?
December 19, 2023
ProSomnus Inc (NASDAQ: OSA) announced the publication of a study by the Cureus Journal of Medical Science, highlighting the company's precision oral appliance therapy (OAT) devices for
Via
Benzinga
Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices
December 19, 2023
Additional clinical research indicates patients using ProSomnus devices have decreased apnea-hypopnea index events per hour, with strong treatment adherence
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
November 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 30, 2023
Via
Benzinga
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
November 30, 2023
Shares of Salesforce, Inc.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 30, 2023
It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
November 17, 2023
Via
Benzinga
ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results
November 09, 2023
Record quarterly revenue of $7.1 million represents an increase of 41.5% year-over-year and seventh consecutive quarter of sequential revenue growth
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus Announces Third Quarter 2023 Investor Call and Business Update
October 31, 2023
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 26, 2023
Gainers
Via
Benzinga
ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference
October 03, 2023
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations
September 21, 2023
Company will leverage new capital inflow to optimize core business operations, advance strategic growth initiatives, and achieve cash flow breakeven
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
EXCLUSIVE: Sleep Disorder Focused ProSomnus Raises $10M To Fuel Growth, Optimize Operations
September 21, 2023
ProSomnus Inc (NASDAQ: OSA) has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital. ProSomnus's Executive Chair, CEO, and...
Via
Benzinga
ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences
September 14, 2023
Scientific Abstracts and Presentations Feature New and Additional Data Demonstrating the Efficacy, Effectiveness, and Safety of ProSomnus Precision Devices for the Treatment of Obstructive Sleep Apnea
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea
August 23, 2023
From
ProSomnus Sleep Technologies, Inc.
Via
GlobeNewswire
EXCLUSIVE: ProSomnus' Device Therapy Better Than Philip's Device(s) For Sleep-Related Breathing Disorder, Study Shows
August 23, 2023
ProSomnus Inc (NASDAQ: OSA), a provider of CPAP alternatives for Obstructive Sleep Apnea, announced updated data presented at the ProSleep Conference earlier this month. The updated data indicate the...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.